Sort:
Date
Filter:
All

3,646 result(s) found

Par Pacific Holdings Stock: Despite The Run-Up In 2023, It Still Looks Solid https://seekingalpha.com/article/4662446-par-pacific-holdings-inc-despite-the-run-up-in-2023-it-still-looks-solid?source=feed_all_articles Jan 11, 2024 - Par Pacific Holdings, a strong player in the energy market, had a 57% gain in the past year and a low valuation. See if it's good to invest in PARR stock.
Cytokinetics Steps Up As Prime Target After Aficamten's HCM Triumph (Rating Upgrade) https://seekingalpha.com/article/4662436-cytokinetics-steps-up-prime-target-aficamtens-hcm-triumph?source=feed_all_articles Jan 11, 2024 - Cytokinetics is almost certainly fielding several bids from a few different companies. Click here to see why CYTK stock is a Buy.
Australia Overall Home Loans Rise 1.0% In November https://www.rttnews.com/3416335/australia-overall-home-loans-rise-1-0-in-november.aspx?type=alleco Jan 11, 2024 - The overall value of home loans in Australia was up a seasonally adjusted 1.0 percent on month in November, the Australian Bureau of Statistics said on Friday = coming in at A$27.58 billion.
Zymeworks Inc. (ZYME) Is Up 1.64% in One Week: What You Should Know https://www.zacks.com/stock/news/2209072/zymeworks-inc-zyme-is-up-1-64-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2209072 Jan 11, 2024 - Does Zymeworks Inc. (ZYME) have what it takes to be a top stock pick for momentum investors? Let's find out.
C4 (CCCC) Up 6% on Restructuring Plan to Curb Cash Burn https://www.zacks.com/stock/news/2209026/c4-cccc-up-6-on-restructuring-plan-to-curb-cash-burn?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2209026 Jan 11, 2024 - The new restructuring plan will allow C4 Therapeutics (CCCC) to extend its cash runway into 2027. The company plans to reduce its workforce by nearly 30%.
KB Home (KBH) Q4 Earnings & Revenues Top, Orders Up 176% https://www.zacks.com/stock/news/2208743/kb-home-kbh-q4-earnings-revenues-top-orders-up-176?cid=CS-ZC-FT-analyst_blog|earnings_article-2208743 Jan 11, 2024 - KB Home (KBH) reports better-than-expected Q4 performance, given improved demand and a lower cancelation rate.
Insiders Are Loading Up On These 2 Big Dividend Stocks https://seekingalpha.com/article/4662142-insiders-are-loading-up-on-these-2-big-dividend-stocks?source=feed Jan 11, 2024 - Insider ownership and accumulation tells us a lot about management’s confidence in the business model. Find out our 2 excellent dividend stock picks.
500 Million Reasons to Buy This Cathie Wood SpaceX Competitor in 2024 https://www.fool.com/investing/2024/01/11/500-million-reasons-to-buy-this-cathie-wood-spacex/?source=iedfolrf0000001 Jan 11, 2024 - Rocket Lab just signed a massive new deal worth up to half a billion dollars.
Bitcoin price rises in aftermath of spot ETF approvals https://seekingalpha.com/news/4054132-bitcoin-price-rises-aftermath-spot-etf-approvals?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news Jan 10, 2024 - The approval of spot bitcoin ETFs by the SEC has boosted the price of BTC-USD, with Bitcoin reaching $46,921, up from $45,556 earlier in the day. Read more here.
Congress Wants Tech Companies to Pay Up for AI Training Data https://www.wired.com/story/congress-senate-tech-companies-pay-ai-training-data/ Jan 10, 2024 - At a Senate hearing on AI’s impact on journalism, lawmakers backed media industry calls to make OpenAI and other tech companies pay to license news articles and other data used to train algorithms.
<<<Page 323>